Posner Christopher (CIK 0001748265)

Latest company ownership

Shares held
13,109
Last filed at
Mar 4, 2025
Confidence Score
49.8
2025Q4
Confidence Score History
2020Q4 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Feb 28, 2025 Mar 4, 2025 Tvardi Therapeutics, Inc. CEO Sell 42.5 -583 -4.26% $2.8K
Feb 4, 2025 Feb 6, 2025 Tvardi Therapeutics, Inc. CEO Sell 46.3 -372 -2.65% $1.8K
Nov 4, 2024 Nov 6, 2024 Tvardi Therapeutics, Inc. CEO Sell 46.3 -3,668 -2.13% $1.1K
Aug 1, 2024 Aug 2, 2024 Tvardi Therapeutics, Inc. CEO Sell 46.3 -4,149 -2.35% $1.5K
May 2, 2024 May 6, 2024 Tvardi Therapeutics, Inc. CEO Sell 46.3 -3,936 -2.18% $3K
Feb 29, 2024 Mar 4, 2024 Tvardi Therapeutics, Inc. CEO Sell 42.5 -5,834 -3.13% $5.2K
Feb 8, 2024 Feb 12, 2024 Tvardi Therapeutics, Inc. CEO Sell 23.8 -35,575 -16.03% $18.9K
Feb 1, 2024 Feb 5, 2024 Tvardi Therapeutics, Inc. CEO Sell 90.0 +57,519 34.98% $2.7K
Nov 2, 2023 Nov 3, 2023 Tvardi Therapeutics, Inc. CEO Sell 46.3 -3,796 -2.26% $4.6K
Aug 3, 2023 Aug 4, 2023 Tvardi Therapeutics, Inc. CEO Sell 45.0 -4,307 -2.50% $13.2K
May 5, 2023 May 9, 2023 Tvardi Therapeutics, Inc. CEO Sell 45.0 -3,869 -2.19% $17K
Mar 3, 2023 Mar 7, 2023 Tvardi Therapeutics, Inc. CEO Sell 37.5 -5,987 -3.28% $58.1K
Feb 2, 2023 Feb 3, 2023 Tvardi Therapeutics, Inc. CEO Sell 45.0 -4,191 -2.25% $49.5K
Nov 16, 2022 Nov 18, 2022 Tvardi Therapeutics, Inc. CEO Sell 32.5 -14,470 -7.20% $161.1K
Apr 4, 2022 Apr 5, 2022 Tvardi Therapeutics, Inc. CEO Sell 51.3 -2,006 -0.99% $25.4K
Jun 3, 2021 Jun 7, 2021 Tvardi Therapeutics, Inc. Director Sell 91.3 +4,896 43.71% $30K
Nov 19, 2020 Nov 23, 2020 Tvardi Therapeutics, Inc. Director Sell 26.3 -2,000 -15.15% $31.6K